CARDURA XL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Cardura Xl, and what generic alternatives are available?
Cardura Xl is a drug marketed by Viatris and is included in one NDA.
The generic ingredient in CARDURA XL is doxazosin mesylate. There are fourteen drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the doxazosin mesylate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Cardura Xl
A generic version of CARDURA XL was approved as doxazosin mesylate by APOTEX on October 18th, 2000.
Summary for CARDURA XL
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 106 |
Clinical Trials: | 11 |
Patent Applications: | 1,730 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for CARDURA XL |
DailyMed Link: | CARDURA XL at DailyMed |
Recent Clinical Trials for CARDURA XL
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
The University of Texas Health Science Center, Houston | Phase 1 |
Brown University | Phase 2 |
University of California, Los Angeles | Phase 3 |
Pharmacology for CARDURA XL
Drug Class | alpha-Adrenergic Blocker |
Mechanism of Action | Adrenergic alpha-Antagonists |
Anatomical Therapeutic Chemical (ATC) Classes for CARDURA XL
US Patents and Regulatory Information for CARDURA XL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Viatris | CARDURA XL | doxazosin mesylate | TABLET, EXTENDED RELEASE;ORAL | 021269-001 | Feb 22, 2005 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Viatris | CARDURA XL | doxazosin mesylate | TABLET, EXTENDED RELEASE;ORAL | 021269-002 | Feb 22, 2005 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for CARDURA XL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Viatris | CARDURA XL | doxazosin mesylate | TABLET, EXTENDED RELEASE;ORAL | 021269-002 | Feb 22, 2005 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for CARDURA XL
See the table below for patents covering CARDURA XL around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Germany | 68910159 | ⤷ Try a Trial | |
Ireland | 890142 | ⤷ Try a Trial | |
Ireland | 62131 | Dosage form for dispensing drug for human therapy | ⤷ Try a Trial |
Canada | 1315687 | FORME GALENIQUE POUR LIBERER UN MEDICAMENT DESTINE AU TRAITEMENT DES HUMAINS (DOSAGE FORM FOR DISPENSING DRUG FOR HUMAN THERAPY) | ⤷ Try a Trial |
Japan | H01242528 | PERMEABLE ADMINISTRATION FORM | ⤷ Try a Trial |
Hong Kong | 1003980 | ⤷ Try a Trial | |
Denmark | 175637 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |